PRTK
Paratek Pharmaceuticals, Inc.
PRTK
PRTK
Delisted
PRTK was delisted on the 20th of September, 2023.
84 hedge funds and large institutions have $44.4M invested in Paratek Pharmaceuticals, Inc. in 2022 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 21 increasing their positions, 31 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
50% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 28
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
84
Holding in Top 10
–
Calls
$173K
Puts
$99K
Top Buyers
| 1 | +$668K | |
| 2 | +$587K | |
| 3 | +$478K | |
| 4 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$454K |
| 5 |
E
Ergoteles
New York
|
+$440K |
Top Sellers
| 1 | -$4M | |
| 2 | -$1.99M | |
| 3 | -$1.59M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$1.18M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$714K |